<DOC>
	<DOCNO>NCT01603342</DOCNO>
	<brief_summary>This trial conduct United States America ( USA ) . The aim trial determine feasibility demonstrate quantifiable change baseline punch biopsy-induced bleeding duration blood loss volume healthy subject receive clopidogrel anti-platelet therapy .</brief_summary>
	<brief_title>A Pilot Study Determine Impact Clopidogrel ( PlavixÂ® ) Bleeding Associated With Punch Biopsies Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<criteria>PT within normal laboratory range The receipt investigational drug within 1 month prior trial Use anticoagulation antiplatelet therapydefined vitamin K antagonist , platelet antagonist , heparin ( low molecular weight heparin ) , aspirin NSAIDs within 30 day prior trial AfricanAmerican race Weight equal 160 kg Recent diagnosis illness would present concomitant trial period</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>